MedPath

The effect of two varying doses of intravenous tranexamic acid on blood loss after vaginal delivery at term in University of Benin Teaching Hospital

Not Applicable
Conditions
primary postpartum haemorrhage
Registration Number
PACTR202310814099421
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
135
Inclusion Criteria

All women with gestation age between 37 completed weeks to 41weeks and 6days and Parity 0-4 admitted in labour (spontaneous labour or induction of labour)
Gave consent for the study
Had vaginal delivery

Exclusion Criteria

Any woman with gestation age between 37 completed weeks to 41weeks and 6days admitted in labour (spontaneous labour or induction of labour) who did not give consent for the study
Any woman who has history of thrombosis or epilepsy, history of medical/surgical conditions involving the heart, liver, kidney and brain, have known allergy to tranexamic acid, and bleeding disorders and abnormalities before pregnancy.
Eventually delivered by Caesarean section after meeting inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
mean blood loss
Secondary Outcome Measures
NameTimeMethod
change in haematocrit and haemoglobin concentration from before and after delivery;need for additional uterotonic;need for blood transfusion
© Copyright 2025. All Rights Reserved by MedPath